Dave Evans
Regular
Thought I’d start a thread on some of BRN’s financial factors where I can add any info I find relevant away from the discussion thread and personal attacks. Don’t care if no one on the forum reads this one, it’s basically for my own research. I’ll add any good info I pick up and ignore the rest.
Last two days have been good ones for BRN, up to $0.31 (20% and 5%). Could be due to the US averting a shutdown and good inflation results following on from this article on the 11/12/2024
BRN’s operational losses over the past 5 years (shown below) are over US$100million
2019 were US$11.31million
2020 were US$26.82 million
2021 were US$20.98 million
2022 were US$22.07 million
2023 were US$28.88 million
BRN is looking at another year of operational losses, already over US$11 million in the 2024 Half Yearly Report.
Millions of shares in remunerations going to KMP and share based expenses are costing millions
2019 - US$ 1.63 million
2020 - US$ 1.43 million
2021 - US$ 4.36 million
2022 - US$ 9.14 million
2023 - US$11.35 million
US$20 million is a lot of money in share based expenses for a company with operational losses of over US$100 million in the same period and half a billion market cap valuation seems high considering US $100 million operational losses, share dilution, multiple capital raises and low revenue
The last jump to $0.30c was after news of hearing aid company Starkey using AI but it had nothing to do with BRN and the SP dropped back to $0.23 within two weeks.
Despite what chippers say there’s always plenty of liquidity and plenty of shares on offer.
Last two days have been good ones for BRN, up to $0.31 (20% and 5%). Could be due to the US averting a shutdown and good inflation results following on from this article on the 11/12/2024
Top Neuromorphic Computing Stocks for 2025: Ranked by Pure-Play Focus
This guide covers the top neuromorphic computing stocks and companies for investors to watch, ranked by their pure-play focus.
exoswan.com
BRN’s operational losses over the past 5 years (shown below) are over US$100million
2019 were US$11.31million
2020 were US$26.82 million
2021 were US$20.98 million
2022 were US$22.07 million
2023 were US$28.88 million
BRN is looking at another year of operational losses, already over US$11 million in the 2024 Half Yearly Report.
Millions of shares in remunerations going to KMP and share based expenses are costing millions
2019 - US$ 1.63 million
2020 - US$ 1.43 million
2021 - US$ 4.36 million
2022 - US$ 9.14 million
2023 - US$11.35 million
US$20 million is a lot of money in share based expenses for a company with operational losses of over US$100 million in the same period and half a billion market cap valuation seems high considering US $100 million operational losses, share dilution, multiple capital raises and low revenue
The last jump to $0.30c was after news of hearing aid company Starkey using AI but it had nothing to do with BRN and the SP dropped back to $0.23 within two weeks.
Despite what chippers say there’s always plenty of liquidity and plenty of shares on offer.
Last edited: